Published

The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ACS pharmacology & translational science
Date: 2025-06-13
Source: PubMed
DOI: 10.1021/acsptsci.5c00208
PubMed: 40534669

Authors

Jensen AA Cecchi CR Hibicke M Bach AH Kaadt E Märcher-Rørsted E Nichols CD Elfving B Kristensen JL

Watch author

Derived topics and classifications

psilocybin Depression Receptor Pharmacology Clinical Trial Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.2025-06-13

Related papers

Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directionsJournal of Psychedelic Studies · 2022-06-09 Is MDD the right target for early-stage psychedelic-assisted therapy trials?Journal of Psychedelic Studies · 2021-09-15 Psilocybin for depression: Considerations for clinical trial designJournal of Psychedelic Studies · 2019-09-01 Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lensJournal of Psychedelic Studies · 2019-02-25 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 Classic psychedelic medicines for adolescent refractory mental health diseaseJournal of Psychedelic Studies · 2026-03-26 Low-income group psilocybin assisted therapy for depression: An Oregon feasibility studyJournal of Psychedelic Studies · 2026-02-12